MAPK7 and cancer: Use of ERK5 siRNA also suggests ERK5 inhibition may have utilityin combination regimens, either with DNA-damaging cancer chemotherapyor with radiation through the modulation of DNA repair,43,44 or other molecular targeted approaches, including acquired resistanceto combined MAPK pathway inhibition.16,45